Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”), the leading autologous (patient’s own) stem cell ...

A bioadaptor implant adaptable to vessel physiology was linked to less target lesion failure and target vessel failure ...

Functional recovery after EVT for AIS varies by race and ethnicity, even though procedural success is similar across groups.

A multi-institution research team led by Georgetown University Medical Center has developed and validated a model estimating ...

Pfizer Inc. reported financial results for the third quarter of 2025 and reaffirmed its 2025 Revenue guidance(1) while raising and narrowing guidance for Adjusted(2) diluted EPS. EXECUTIVE COMMENTARY ...

Chronic subdural hematoma (cSDH) is frequently encountered in neurosurgical practice. Apart from traditional treatment approaches, such as surgical intervention or medical management, middle meningeal ...

Point-of-care ultrasound (POCUS) is a simple and rapid diagnostic method used in emergency medicine to supplement physical examinations and guide treatment decisions. Technological advances and the ...